PANTHER is born from the lessons learned during the COVID-19 pandemic in Africa. This experience highlighted that Low and Middle-income Countries (LMICs) need to be better prepared to accelerate the clinical research response to new infectious disease outbreaks in Africa. The region still faces administrative, financing, and regulatory bottlenecks that should be overcome.
PANTHER was designed to address these hurdles and to prompt response to emerging pandemics. PANTHER aims to enable African countries to be self-sufficient in research and development of medical products, drugs, or strategies that, in turn, allow them to craft and improve their response systems.
In the COVID-19 crisis, LMICs’ needs were not sufficiently integrated into global priority setting and response. PANTHER’s ambition is to revert this imbalance. This is why the platform will strongly align with WHO R&D blueprint, AFRO, EMRO and Africa CDC priorities.
PANTHER will propose a new approach based on a collaborative research model to rapidly develop more concrete, inclusive, and sustainable operational preparedness and response plans in Africa.
PANTHER is built on existing partnerships between key African and European research institutions engaged in ANTICOV or other research projects and will strive to collaborate with other existing networks and partners on the African continent.